← Back to Clinical Trials
Recruiting NCT07193329

NCT07193329 Psychological Distress in Malignant Tumor Patients: Effects on Treatment Adherence, Outcomes, and Quality of Life

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07193329
Status Recruiting
Phase
Sponsor Gang Chen, MD
Condition Psychological Distress
Study Type OBSERVATIONAL
Enrollment 2,000 participants
Start Date 2025-07-22
Primary Completion 2028-07-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 2,000 participants in total. It began in 2025-07-22 with a primary completion date of 2028-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this observational study is to learn about the Psychological Distress in Malignant Tumor Patients about Effects on Treatment Adherence, Outcomes, and Quality of Life. The main question it aims to answer is: Does Psychological Distress affect Malignant Tumor Patients' Effects on Treatment Adherence, Outcomes, and Quality of Life? Malignant Tumor Patients with or without Psychological Distress will answer GAD-7 and PHQ-9 and their Treatment Adherence, Outcomes, and Quality of Life be recorded for 3 years.

Eligibility Criteria

Inclusion Criteria: * (1) Confirmed malignant tumors by imaging or pathology (such as hepatobiliary carcinoma, gastric cancer, breast cancer, lung cancer, etc.) * (2) Planning to receive or currently undergoing systemic treatment (such as surgery, chemotherapy, TACE, targeted therapy, etc.) * (3) Age ≥18 years old * (4) Sign the informed consent form and voluntarily participate in this study Exclusion Criteria: * (1) Combined with severe systemic diseases (such as severe cardiovascular and cerebrovascular diseases) * (2) There is severe cognitive impairment and it is impossible to complete the questionnaire assessment * (3) Incomplete clinical data or loss to follow-up

Frequently Asked Questions

Who can join the NCT07193329 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Psychological Distress. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07193329 currently recruiting?

Yes, NCT07193329 is actively recruiting participants. Visit ClinicalTrials.gov or contact Gang Chen, MD to inquire about joining.

Where is the NCT07193329 trial being conducted?

This trial is being conducted at Wenzhou, China.

Who is sponsoring the NCT07193329 clinical trial?

NCT07193329 is sponsored by Gang Chen, MD. The trial plans to enroll 2,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology